Stockreport

Clovis Oncology Announces Third Quarter 2019 Operating Results

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF $37.6M in Rubraca® (rucaparib) net product revenue for Q3 2019, up 65% year over yearNet product revenue increased 14% sequentially in Q3 2019 compared to Q2 2019, inclu [Read more]